Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Inv. presentation
Quarterly results
Director comp.
Appointed COO

Jasper Therapeutics, Inc. (AMHCU) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/13/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/13/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/13/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/26/2023 4 CROSS HERB (CFO) has filed a Form 4 on Jasper Therapeutics, Inc.
Txns: Granted 550,000 options to buy @ $0.78, valued at $429k
06/08/2023 4 Kapoor Vishal (Director) has filed a Form 4 on Jasper Therapeutics, Inc.
Txns: Granted 47,000 options to buy @ $1.6, valued at $75.2k
06/08/2023 4 Klein Lawrence Otto (Director) has filed a Form 4 on Jasper Therapeutics, Inc.
Txns: Granted 47,000 options to buy @ $1.6, valued at $75.2k
06/08/2023 4 EMSTER KURT VON (Director) has filed a Form 4 on Jasper Therapeutics, Inc.
Txns: Granted 47,000 options to buy @ $1.6, valued at $75.2k
06/08/2023 4 Shizuru Judith Anne (Director) has filed a Form 4 on Jasper Therapeutics, Inc.
Txns: Granted 47,000 options to buy @ $1.6, valued at $75.2k
06/08/2023 4 Nolet Chris (Director) has filed a Form 4 on Jasper Therapeutics, Inc.
Txns: Granted 47,000 options to buy @ $1.6, valued at $75.2k
06/08/2023 4 Lis William (Director) has filed a Form 4 on Jasper Therapeutics, Inc.
Txns: Granted 47,000 options to buy @ $1.6, valued at $75.2k
06/08/2023 4 French Anna Louise (Director) has filed a Form 4 on Jasper Therapeutics, Inc.
Txns: Granted 47,000 options to buy @ $1.6, valued at $75.2k
04/14/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/14/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/14/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/14/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/14/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/20/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/20/2023 4 MARTELL RON (President, CEO and Director) has filed a Form 4 on Jasper Therapeutics, Inc.
Txns: Granted 500,000 options to buy @ $1.87, valued at $935k
02/03/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/31/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/26/2023 4 ROCHE HOLDING LTD (10% Owner) has filed a Form 4 on Jasper Therapeutics, Inc.
Txns: Sold 75,000 shares @ $1.89, valued at $141.8k
10/13/2022 4 MARTELL RON (President, CEO and Director) has filed a Form 4 on Jasper Therapeutics, Inc.
Txns: Granted 506,250 shares @ $0
10/13/2022 4 Klein Lawrence Otto (Director) has filed a Form 4 on Jasper Therapeutics, Inc.
Txns: Granted 24,500 shares @ $0
10/13/2022 4 EMSTER KURT VON (Director) has filed a Form 4 on Jasper Therapeutics, Inc.
Txns: Granted 30,250 shares @ $0
10/13/2022 4 Shizuru Judith Anne (Director) has filed a Form 4 on Jasper Therapeutics, Inc.
Txns: Granted 29,500 shares @ $0
10/13/2022 4 Mahal Jeetinder Singh (See Remarks) has filed a Form 4 on Jasper Therapeutics, Inc.
Txns: Granted 214,722 shares @ $0
10/13/2022 4 Nolet Chris (Director) has filed a Form 4 on Jasper Therapeutics, Inc.
Txns: Granted 32,500 shares @ $0
10/13/2022 4 Lis William (Director) has filed a Form 4 on Jasper Therapeutics, Inc.
Txns: Granted 29,500 shares @ $0
10/13/2022 4 French Anna Louise (Director) has filed a Form 4 on Jasper Therapeutics, Inc.
Txns: Granted 30,750 shares @ $0
06/28/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/08/2022 4 Mahal Jeetinder Singh (See Remarks) has filed a Form 4 on Jasper Therapeutics, Inc.
Txns: Granted 48,441 options to buy @ $3.12, valued at $151.1k
03/23/2022 4 MARTELL RON (President, CEO and Director) has filed a Form 4 on Jasper Therapeutics, Inc.
Txns: Granted 1,704,328 options to buy @ $3.54, valued at $6M
03/23/2022 4 Klein Lawrence Otto (Director) has filed a Form 4 on Jasper Therapeutics, Inc.
Txns: Granted 78,045 options to buy @ $3.54, valued at $276.3k
03/23/2022 4 EMSTER KURT VON (10% Owner) has filed a Form 4 on Jasper Therapeutics, Inc.
Txns: Granted 78,045 options to buy @ $3.54, valued at $276.3k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy